TipRanks
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
US Market
BRTX
BioRestorative Therapies
RESEARCH TOOLSreports
Want to see BRTX full AI Analyst Report?

BioRestorative Therapies (BRTX) Income Statement

319 Followers

BioRestorative Therapies Income Statement

Last quarter (Q1 2026), BioRestorative Therapies's total revenue was $23.17K, a decrease of -7.32% from the same quarter last year. In Q1, BioRestorative Therapies's net income was $-2.15M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 359.70K$ 401.00K$ 145.80K$ 119.80K$ 46.00K
Gross Profit
$ 335.86K$ 372.93K$ 145.80K$ 119.80K$ 46.00K
Operating Expenses
$ 15.98M$ 11.93M$ 15.37M$ 18.98M$ 26.35M
Depreciation and Amortization
$ 209.99K$ 189.06K$ 165.74K$ 120.55K$ 89.11K
EBITDA
$ -14.03M$ -8.79M$ -14.97M$ -13.10M$ -42.40M
Operating Income
$ -15.65M$ -11.56M$ -15.22M$ -18.86M$ -26.31M
Other Income/Expenses
$ 1.41M$ 2.58M$ 4.80M$ 5.64M$ -18.00M
Pretax Income
$ -14.24M$ -8.98M$ -10.42M$ -13.22M$ -44.30M
Net Income
$ -14.24M$ -8.98M$ -10.42M$ -13.22M$ -44.30M
Per Share Metrics
Basic EPS
$ -31.60$ -23.20$ -49.40$ -73.00$ -746.00
Diluted EPS
$ -31.60$ -23.20$ -49.40$ -73.00$ -746.00
Weighted Average Shares Outstanding
 449.66K 388.20K 210.92K 180.89K 59.39K
Weighted Average Shares Outstanding (Diluted)
 449.66K 388.20K 210.92K 180.89K 59.39K
Currency in USD

BioRestorative Therapies Earnings and Revenue History